INS and type 1 diabetes mellitus: Experiments using intravenous infusion of GLP-1 in patients with T1DM reduced glucose levels and inhibited glucagon secretion, partly because of GLP-1 augmented insulin sensitivity as well as due to the effect of GLP-1 on gastric emptying [11], the latter playing a role primarily in insulin-deficient T1DM patients [16].